Treatment of non-small-cell lung cancer with erlotinib or gefitinib

Vince D. Cataldo, Don L. Gibbons, Román Pérez-Soler, Alfonso Quintás-Cardama

Research output: Contribution to journalArticle

281 Scopus citations


A 64-year-old woman who has never smoked receives the diagnosis of stage I adenocarcinoma of the lung and undergoes right upper lobectomy. One year later, bone and liver metastases develop. She is treated with carboplatin, paclitaxel, and bevacizumab, but progressive bone metastases are noted after 6 weeks of therapy. An oncologist recommends the initiation of erlotinib therapy.

Original languageEnglish (US)
Pages (from-to)947-955
Number of pages9
JournalNew England Journal of Medicine
Issue number10
StatePublished - Mar 10 2011


ASJC Scopus subject areas

  • Medicine(all)

Cite this